Scientists at Rutgers University–Newark have developed a first-of-its-kind RNA-based nanotechnology that assembles itself inside living human cells and can be programmed to stop propagation of harmful ...
Researchers from the National University of Singapore (NUS) have developed a "capping-and-coupling" strategy to transform naturally occurring (native) sugars directly into compounds known as ...
Leveraging its integrated "design-synthesis-quality control" system, Creative Biolabs is overcoming bottlenecks in mRNA ...
The merger process reached its formal conclusion on January 6, 2026, with Mainz-based BioNTech SE becoming the sole owner. The operational entity, CureVac Merger B.V., has replaced the original ...
AZoLifeSciences on MSN
Single enzyme enables low-cost synthesis of all RNA nucleotides
A single enzyme that can generate all four nucleotide triphosphates, the building blocks of ribonucleic acid (RNA), was ...
A single enzyme that can generate all four nucleoside triphosphates, the building blocks of ribonucleic acid (RNA), has been ...
SARS-CoV-2 evolution, particularly the emergence of Omicron variants, has challenged vaccine efficacy, necessitating antigens with broad and variant-specific protection. To design mRNA vaccine ...
At the mRNA Health conference in Berlin, enginzyme and AGC Inc. presented a scalable process to produce a key mRNA vaccine and therapy ingredient, N1-methylpseudouridine-5'-triphosphate (m¹?TP). The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results